| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Legal Officer
1 company
Tryn Stimart is Chief Legal Officer at ABCL. Tryn Stimart's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $3K at current prices.
The ABCL filings lean toward selling, a net 999,500 shares.
Tryn Stimart has 8 Form 4 filings on record from December 2020 to January 2026, all as Chief Legal Officer at AbCellera Biologics (ABCL), 2020–2026.
The 12 reported transactions were 7 option or other derivative awards, 2 option exercises, 2 open-market purchases and 1 open-market sale.
Counted by filing, the open-market trades come to 1 purchase worth about $10K and 1 sale worth about $25.5M.
The only open-market purchase was 500 shares of ABCL at an average $20.00 on December 15, 2020, about $10K.
The only open-market sale was 1,000,000 shares of ABCL at an average $25.50 on June 9, 2021, about $25.5M. Twelve months later ABCL was down 65%.